Royal college

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

Retrieved on: 
화요일, 4월 2, 2024

WATERTOWN, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced the appointment of leading global ophthalmologists to its Scientific Advisory Board (SAB), co-chaired by Carl Regillo M.D., FACS, Chief of the Retina Service at Wills Eye Hospital and Charles Wykoff, M.D., Ph.D., Director of Research of Retina Consultants of Texas. The SAB additions include Usha Chakravarthy, M.B.B.S., Ph.D.; Allen Ho, M.D. FACS FASRS, and Frank Holz, M.D., F.E.B.O., F.A.R.V.O. These three world-renowned retinal specialists will support advancement of the Company’s global clinical strategy ahead of the anticipated initiation of its Phase 3 pivotal trials in wet age-related macular degeneration (wet AMD) in the second half of this year. Additionally, the Company announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the trade name, DURAVYUTM (vorolanib intravitreal insert) for the Company’s lead product candidate, EYP-1901.

Key Points: 
  • “The SAB’s strategic counsel, global expertise, and scientific knowledge will be incredibly valuable during this critical time in EyePoint’s growth and expansion.
  • Dr. Chakravarthy has authored or co-authored over 400 publications, and she is invited to lecture in the UK and abroad.
  • FACS FASRS is Attending Surgeon, Director of Retina Research and Co-Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.
  • He is a Board Member of the German Ophthalmological Society, and of the Club Jules Gonin and is past president of EURETINA.

Autolus Therapeutics Announces Changes to its Board of Directors

Retrieved on: 
월요일, 4월 1, 2024

John H. Johnson advised the Board of his decision to step down from his role as Chairman of the Board and Non-Executive Director.

Key Points: 
  • John H. Johnson advised the Board of his decision to step down from his role as Chairman of the Board and Non-Executive Director.
  • We wish John much success with his new projects,” said Dr. Christian Itin, Chief Executive Officer of Autolus.
  • He is currently a director of Alnylam Pharmaceuticals and chair of Dunad Therapeutics and Gulf of Maine Research Institute.
  • Mr. Bonney has served as a director with many companies previously including Celgene, Kaleido Biosciences, Magenta Therapeutics, Bristol Myers Squibb, Sarepta Therapeutics and Syros Pharmaceuticals.

The Aesthetic Society Urges Immediate Action: Stronger Regulations of Outpatient Aesthetic Surgery in California and Across the United States

Retrieved on: 
금요일, 4월 5, 2024

This article explores an alarming lack of regulation for physicians performing outpatient aesthetic surgeries in California.

Key Points: 
  • This article explores an alarming lack of regulation for physicians performing outpatient aesthetic surgeries in California.
  • Dr. Melinda Haws, President of The Aesthetic Society, emphasized the importance of patient safety and the need for stringent regulations in aesthetic medicine.
  • All members of The Aesthetic Society and The California Society of Plastic Surgeons are ABPS board-certified.
  • As a professional body, The Aesthetic Society is dedicated to advocating for patient safety and upholding the highest standards of care in the field of aesthetic surgery.

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

Retrieved on: 
월요일, 3월 18, 2024

ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that Victor Chong, M.D., MBA was appointed Chief Medical Officer on March 14, 2024.

Key Points: 
  • ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that Victor Chong, M.D., MBA was appointed Chief Medical Officer on March 14, 2024.
  • George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer of Clearside, commented, “Victor is a well-known and well-respected retinal clinician and scientist, who is a strategically focused and visionary leader.
  • We are delighted to have him join the Clearside team.
  • “With the upcoming ODYSSEY data and extensive partnership portfolio, this is an exciting time to join Clearside.

Dr. Mark Viktor Silver – Maintains Unique Double Board Certification

Retrieved on: 
월요일, 3월 11, 2024

Dr. Mark Viktor Silver , founder of the Silver Spine and Neurological Center , has maintained the unique distinction of being board-certified in neurosurgery by both the American Board of Neurological Surgery (ABNS) and the Royal College of Physicians and Surgeons of Canada.

Key Points: 
  • Dr. Mark Viktor Silver , founder of the Silver Spine and Neurological Center , has maintained the unique distinction of being board-certified in neurosurgery by both the American Board of Neurological Surgery (ABNS) and the Royal College of Physicians and Surgeons of Canada.
  • With more than 20 years of practice, Dr. Silver specializes in minimally invasive and complex neurosurgical procedures aimed at alleviating neck, back, arm, and leg pain.
  • “While not required for a medical license, the rigorous board certification process shows a physician’s commitment to his patients and profession,” said Dr. Silver.
  • With 21 years of professional practice, Dr Silver has worked in large academic and private institutions and has served as Chief of Neurosurgery at various prestigious hospitals.

The Inner Circle acknowledges Antony Jackson Arumairaj, MD as a Top Pinnacle Physician

Retrieved on: 
화요일, 4월 2, 2024

JERSEY CITY, N.J., April 2, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Antony Jackson Arumairaj, MD is acknowledged as a Top Pinnacle Physician for his contributions as a Distinguished Internal Medicine Specialist.

Key Points: 
  • JERSEY CITY, N.J., April 2, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Antony Jackson Arumairaj, MD is acknowledged as a Top Pinnacle Physician for his contributions as a Distinguished Internal Medicine Specialist.
  • In this capacity, he not only provides exceptional patient care but also plays a pivotal role in teaching and mentoring medical students.
  • His dedication to the well-being of his patients and commitment to medical education make him a valuable asset to the healthcare community.
  • He aims to complete his Pulmonary Critical Care fellowship and become an Attending Physician at a university hospital.

University of Medicine and Health Sciences Names Award-Winning Medical Educator and Physician Dr. Shivayogi Bhusnurmath as Dean of Basic Sciences

Retrieved on: 
화요일, 3월 26, 2024

NEW YORK, March 26, 2024 /PRNewswire-PRWeb/ -- The University of Medicine and Health Sciences, (UMHS), a small, mission-driven medical school with a commitment to student support and a legacy of successful residency placements in the United States and Canada, has named Dr. Shivayogi Bhusnurmath, an award-winning medical educator and pioneering physician, as its new Dean of Basic Sciences. Dr. Bhusnurmath will advance the university's focus on providing quality medical education, preparing future doctors to deliver compassionate care, and ensuring the continued growth and development of UMHS.

Key Points: 
  • Dr. Bhusnurmath will advance the university's focus on providing quality medical education, preparing future doctors to deliver compassionate care, and ensuring the continued growth and development of UMHS.
  • His approach resonates deeply with our mission of delivering personalized education and preparing our graduates to lead with compassion and distinction."
  • Dr. Bhusnurmath has spent four decades developing curriculum at leading medical schools and brings with him a wealth of medical knowledge, clinical experience, and academic leadership.
  • Trained in India at the prestigious Postgraduate Institute of Medical Education and Research, Chandigarh, Dr. Bhusnurmath obtained his Fellowship from the Royal College of Pathologists, London.

The Aesthetic Society and The Aesthetic Foundation Launch ARISE-- American Registry for Breast Implant Surveillance

Retrieved on: 
화요일, 3월 19, 2024

GARDEN GROVE, Calif., March 19, 2024 /PRNewswire/ -- The Aesthetic Society, the leading authority on aesthetic plastic surgery, and The Aesthetic Foundation, the philanthropic research and education arm of The Aesthetic Society, proudly announce the launch of the American Registry for Breast Implant Surveillance (ARISE), powered by their innovative Aesthetic One app. ARISE revolutionizes the landscape of breast implant registries by partnering with Aesthetic One, an FDA-recognized app dedicated to digital registration of breast implant devices used in aesthetic and reconstructive cases. 

Key Points: 
  • GARDEN GROVE, Calif., March 19, 2024 /PRNewswire/ -- The Aesthetic Society, the leading authority on aesthetic plastic surgery, and The Aesthetic Foundation, the philanthropic research and education arm of The Aesthetic Society, proudly announce the launch of the American Registry for Breast Implant Surveillance (ARISE), powered by their innovative Aesthetic One app.
  • ARISE revolutionizes the landscape of breast implant registries by partnering with Aesthetic One, an FDA-recognized app dedicated to digital registration of breast implant devices used in aesthetic and reconstructive cases.
  • Through Aesthetic One, surgeons can effortlessly register implants with the manufacturers to enable the warranty and proper device tracking while also contributing vital data to the American Registry for Breast Implant Surveillance (ARISE).
  • This collaboration offers a purpose-driven, comprehensive platform for tracking implants and analyzing data related to breast implant devices and surgeries.

Pioneering industrial refrigeration engineer, Dr Forbes Pearson, dies at 92

Retrieved on: 
월요일, 3월 18, 2024

GLASGOW, Scotland, March 18, 2024 /PRNewswire-PRWeb/ -- Stephen Forbes Pearson was the first child of Stephen H Pearson, an engineer from Northumberland, and Gladys Stewart, from Glasgow. Forbes was born in Pollokshields, Glasgow, on 25 June 1931 and attended school at Paisley Grammar and then Kelvinside Academy. He was a precocious child who loved learning and absorbed facts easily, particularly about the natural sciences. In infant school, he was reprimanded for arguing with a teacher who had told the class that the earth was a sphere. "No, it's an oblate spheroid" he said. Despite a bout of pleurisy as a teenager that required a lengthy recuperation, he enjoyed playing rugby as a front row forward, where he reckoned his short legs and stocky body gave him a particular mechanical advantage.

Key Points: 
  • Forbes was born in Pollokshields, Glasgow, on 25 June 1931 and attended school at Paisley Grammar and then Kelvinside Academy.
  • He spent undergraduate summer vacations working in the Rolls Royce factory at Hillington and the Tecumseh compressor factory in Michigan.
  • They also shared a love of language and a rather coarse sense of humour that sometimes took others by surprise.
  • As Chief Engineer for Sterne his work was divided between design of products, such as industrial compressors and heat exchangers, and design of industrial refrigeration systems.

Supporting Internationally Educated Nurses joining the Canadian health workforce

Retrieved on: 
목요일, 3월 14, 2024

This investment will support the integration of Internationally Educated Nurses (IENs) into Canada's health care system.

Key Points: 
  • This investment will support the integration of Internationally Educated Nurses (IENs) into Canada's health care system.
  • This investment will help more Internationally Educated Nurses join the workforce in Canada to help our current workforce and get more nurses into our health care system even faster."
  • Our government is committed to supporting both the recruitment and retention of this vital workforce and integrating more Internationally Educated Nurses into the workforce is a critical piece of this approach."
  • This announcement is part of the Government of Canada's larger and ongoing efforts to support the health workforce, including:
    A federal, provincial and territorial statement on supporting Canada's health workforce which outlines collaborative actions underway to address challenges facing Canada's health workforce including working together to address retention issues, undertaking a study of the education and training supply and demand for key health professions, reducing the time it takes for internationally educated health professionals to join our health workforce, increasing the sharing and standardization of health workforce data, and more.